HKEX Stock Code: 01093English|繁體|简体

2024 3Q Results

  • Revenue RMB 22,686M, -4.9%
  • Underlying profit attributable to shareholders RMB 3,999M, -15.2%
  • Reported profit attributable to shareholders RMB 3,778M, -15.9%
  • Basic earnings per share (underlying profit) RMB 33.90 cents, -14.6%
  • Basic earnings per share (reported profit) RMB 32.03 cents, -15.4%

Highlight - 2024 3Q

Revenue
RMB22,686M, -4.9%
Underlying profit attributable to shareholders
RMB3,999M, -15.2%
Reported profit attributable to shareholders
RMB3,778M, -15.9%
Basic earnings per share (reported)
RMB33.90 cents, -14.6%
Basic earnings per share (underlying profit)
RMB32.03 cents, -15.4%

Corporate Governance

Corporate Governance

Financial Calendar

Nov
15
Nov
15
Aug
21
Aug
21
May
28
May
27
May
27
Mar
20
Mar
20

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.